HUMAN ANTIBODIES THAT BINDING LYMPHOCYTE ACTIVATION GENE-3 (LEG-3), AND USES THEREOF
CY1125618T1Undetermined Publication Date: 2026-04-17ER SQUIBB & SONS LLC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20221100674T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2008-08-11
- Filing Date
- 2022-10-12
- Publication Date
- 2026-04-17
- Estimated Expiration
- 2042-10-12
Abstract
The present disclosure provides isolated human monoclonal antibodies and antigen-binding fragments thereof that bind to human LAG-3, particularly antibodies and antigen-binding antibody fragments that can inhibit the binding of LAG-3 to MHC Class II molecules and that can stimulate antigen-specific T cell responses. Nucleic acid molecules encoding the antibodies and antigen-binding fragments of the invention as well as compositions and immunoconjugates of the antibodies and antigen-binding antibody fragments of the invention are also provided. This disclosure also provides for the use of the antibodies and antigen-binding antibody fragments of the invention in therapy.
Need to check novelty before this filing date? Find Prior Art